Hydroxychloroquine sulfate for lung diseases

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trials ended early. Its trials were stopped early. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 Apr 2020: Trial registered, NCT04361461
  2. 8 Sep 2026: Trial withdrawn, NCT04361461

The trials

NCT04361461: Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

State
Withdrawn before it started
Phase
Phase 3
People
0 taking part
Started
30 Apr 2020
Primary completion
4 Nov 2020
Arms
Group 1
Results
None posted
  1. 24 Apr 2020: Trial registered
  2. 8 Sep 2026: Trial withdrawn

How the status changed

  1. 19 Nov 2026: First set: Trials ended early

About the treatment

Kind of treatment: Drug.

Also known as Ercoquin, Oxiklorin, Plaquenil, Plaquenil sulfate, Quensyl.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.